2026 ADA Guidelines Standards of Care in Diabetes: Pharmacological Management of Type 2 Diabetes Mellitus
VIOLET Study Summary: Real World Evaluation of Vildagliptin and Vildagliptin + Metformin in Type 2 Diabetes Patients (DRC 2025)
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.
Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.
Transplant centers' prophylaxis and monitoring strategies: a key determinant of current herpes and polyomavirus incidences - results from the DZIF kidney transplant cohort.
